Cancer Research Annual Meeting 2010  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, Y.
Right arrow Articles by Fontana, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, Y.
Right arrow Articles by Fontana, J. A.
[Cancer Research 60, 2025-2032, April 1, 2000]
© 2000 American Association for Cancer Research


Tumor Biology

S-phase Arrest and Apoptosis Induced in Normal Mammary Epithelial Cells by a Novel Retinoid1

Yuxiang Zhang, Arun K. Rishi, Marcia I. Dawson, Rainbow Tschang, Lulu Farhana, Madanamohan Boyanapalli, Uwe Reichert, Braham Shroot, Eric C. Van Buren and Joseph A. Fontana2

John D. Dingell VA Medical Center [Y. Z., A. K. R., R. T., L. F., M. B., J. A. F.] and Karmanos Cancer Institute, Detroit, Michigan 48201 [Y. Z., A. K. R., R. T., L. F., M. B., E. C. V. B., J. A. F.]; Molecular Medicine Research Institute, Mountain View, California 94043 [M. I. D]; and Center International de Rescherches Dermatologigues Galderma, F. 06902 Valbonne, France [U. R., B. S.]

The addition of all-trans-retinoic acid has been found to mediate a G1 cell cycle phase arrest but not apoptosis in normal mammary epithelial cells. We have now found that addition of the novel retinoid 6-[3-(1-adamanty1)]-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437), which appears to function through a pathway independent of retinoic acid nuclear receptors, results in an S-phase arrest that is preceded by a 4-fold elevation in the levels of the cyclin-cyclin dependent kinase (cdk) inhibitor p21WAF1/CIP1. Failure to inhibit E2F-1 activation of genes through its phosphorylation by the cyclin cdk2 kinase has been shown to result in S-phase arrest and apoptosis in a number of cell types. Although exposure of the normal mammary cells to CD437 does not result in modulation of cyclin A or cdk2 levels, an increase in E2F-1 levels and a marked inhibition of cyclin A/cdk2 kinase activity are observed. Exposure to CD437 results in enhanced E2F-1 binding to its DNA consensus sequences and transcriptional activity during S phase. We hypothesize that this enhanced E2F-1 transcriptional activity results in S-phase arrest and subsequent apoptosis that has been observed in other systems.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
C. Valli, G. Paroni, A. M. Di Francesco, R. Riccardi, M. Tavecchio, E. Erba, A. Boldetti, M. Gianni', M. Fratelli, C. Pisano, et al.
Atypical retinoids ST1926 and CD437 are S-phase-specific agents causing DNA double-strand breaks: significance for the cytotoxic and antiproliferative activity
Mol. Cancer Ther., September 1, 2008; 7(9): 2941 - 2954.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Farhana, M. I. Dawson, and J. A. Fontana
Apoptosis Induction by a Novel Retinoid-Related Molecule Requires Nuclear Factor-{kappa}B Activation
Cancer Res., June 1, 2005; 65(11): 4909 - 4917.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Li, X. Sun, J. T. LaMont, A. B. Pardee, and C. J. Li
Selective killing of cancer cells by beta -lapachone: Direct checkpoint activation as a strategy against cancer
PNAS, March 4, 2003; 100(5): 2674 - 2678.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Farhana, M. Dawson, A. K. Rishi, Y. Zhang, E. Van Buren, C. Trivedi, U. Reichert, G. Fang, M. W. Kirschner, and J. A. Fontana
Cyclin B and E2F-1 Expression in Prostate Carcinoma Cells Treated with the Novel Retinoid CD437 Are Regulated by the Ubiquitin-mediated Pathway
Cancer Res., July 1, 2002; 62(13): 3842 - 3849.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S.-B. Lin, P. O. P. Ts'o, S.-K. Sun, K.-B. Choo, F.-Y. Yang, Y.-P. Lim, H.-L. Tsai, and L.-C. Au
Inhibition of Thymidylate Synthase Activity by Antisense Oligodeoxynucleotide and Possible Role in Thymineless Treatment
Mol. Pharmacol., September 1, 2001; 60(3): 474 - 479.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Potapova, M. Gorospe, F. Bost, N. M. Dean, W. A. Gaarde, D. Mercola, and N. J. Holbrook
c-Jun N-terminal Kinase Is Essential for Growth of Human T98G Glioblastoma Cells
J. Biol. Chem., August 4, 2000; 275(32): 24767 - 24775.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.